AGIOS PHARMACEUTICALS, INC.
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2016 | -55.3% | -55.3% | -32.1% |
| FY2017 | -83.8% | -83.8% | -51.2% |
| FY2018 | -50.3% | -50.3% | -40.3% |
| FY2019 | -64.2% | -64.2% | -46.2% |
| FY2020 | -81.9% | -81.9% | -38.4% |
| FY2021 | 124.2% | 124.2% | 111.6% |
| FY2022 | -21.1% | -21.1% | -18.7% |
| FY2023 | -43.4% | -43.4% | -37.6% |
| FY2024 | 43.7% | 43.7% | 40.5% |
| FY2025 | -34.6% | -34.6% | -31.8% |